Co-Director Cancer Genetics Baylor Scott & White Health Dallas, Texas, United States
The purpose of this workshop is to educate participants on the epidemiology of mCRC, importance of BRAF as a prognostic and targetable biomarker, methods of testing for BRAF mutations, when to test patients with mCRC for BRAF mutations, and the role of multidisciplinary collaboration in testing.
